Navigation Links
The Conferences Forum Launches Patients as Partners Event
Date:11/25/2013

New York, NY (PRWEB) November 25, 2013

The Conference Forum is proud to present Patients as Partners with CISCRP’s founder Ken Getz as conference chair, along with an exciting speaking faculty representing industry, advocacy, academia, patients and the FDA. Together, they address the latest strategies, technologies and policies to vastly improve the patient experience in clinical trials. The conference addresses how sponsors of clinical trials can realistically partner with patients and how patients can partner with sponsors to meet the demands of:

  • Evolving Science: Personalized Medicine
  • Higher Quality Data
  • Lower Dropout Rates
  • New Therapies Faster to Market

Patients as Partners takes a broad view of the patient experience and how we engage with patients across the entire clinical trial continuum. This includes early research, patient-centric protocol design, recruitment, retention, engagement, and communicating results with patients acting as ambassadors and educators.

“If you put the patient lens in front, you start to come up with some really solid answers and solutions.” - Jeffrey Kasher, PhD, Eli Lilly

The conference is designed for clinical trial executives in pharma and biotech, directors in patient advocacy and academia, and service providers who are looking to incorporate the patient perspective throughout the clinical trial process, valuing patients and treating them as partners, ultimately leading to more successful clinical trials. Take advantage of the first early bird and register by December 20th.

Speaking Faculty:

  •     Annette Bar-Cohen, MA, MPH, Executive Director, Center for NBCC Advocacy Training
        National Breast Cancer Coalition
  •     Lily Cappelletti, Associate Director, Research Partnerships, The Michael J. Fox
        Foundation for Parkinson’s Research
  •     Lama Chahine, MD, Instructor of Neurology, Parkinson's Disease and Movement
        Disorders Center,University of Pennsylvania
  •     Jacqueline Cole, Clinical Operations Portfolio Management, Oncology, Eli Lilly
  •     Maria Corvez, Clinical Research Manager II, Millennium Pharmaceuticals
  •     Iris Culbert, Senior Clinical Project Manager, Global Clinical Operations, Teva
        Pharmaceuticals
  •     Daniel Davis, Oncology Business Unit Advisor, Eli Lilly
  •     Victoria DiBiaso, Head of Investigator & Patient Networks, Sanofi Genzyme
  •     Adam Dole, Presidential Innovation Fellow, The White House*
  •     Ken Getz, MBA, Director of Sponsored Research / Founder, Tufts CSDD / CISCRP
  •     Stuart Horowitz, PhD, MBA, President, Global Professional Services, WIRB Copernicus
        Group
  •     Andreas Koester, MD, PhD, VP, Clinical Trial Innovation & External Alliances, Janssen
  •     Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer
  •     Debra Lounsbury, Principal Scientist, BioMarin
  •     Kimberly McCleary, Director, Strategic Initiatives, FasterCures
  •     Nariman Nasser,Digital Strategist, Genentech
  •     Bray Patrick-Lake, BS, MFS, Director of Stakeholder Engagement, Clinical Trials
        Transformation Initiative
  •     Christine Pierre, President, Society for Clinical Research Sites
  •     Tomasz Sablinski, MD, PhD, Founder & CEO, Transparency Life Sciences
  •     Jean Slutsky, PA, MSPH, Director, Center for Outcomes and Evidence Agency for
        Healthcare Research and Quality
  •     Komathi Stem, Senior Director, Product Development, Innovation Lead, Genentech
  •     Andrea Tan, Operations Research Analyst, Office of Strategic Programs, CDER, FDA
  •     Ronnie Todaro, Vice President, National Programs / Co-Chair, Parkinson’s Disease
        Foundation / CTTI Patient Leadership Council
  •     Jennifer Wulff, Director, Clinical Innovation, Pfizer*
  •     Anthony Yanni, Head of Patient Value & Strategy, Sanofi Genzyme

*Invited speakers

About The Conference Forum
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. Its mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals. See more at: http://theconferenceforum.org/.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11339391.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dyadic International To Present At Two Major Conferences In December 2013
2. Aratana Therapeutics to Present at Two Upcoming Investor Conferences
3. Bone Biologics Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. BioLight Israeli Life Sciences Investments Ltd. to Webcast, Live, at RetailInvestorConferences.com on September 12th
5. Trovagene to Present at Two Healthcare Conferences
6. ANP to present at and attend major US investment, partnering and industry conferences
7. SPIE Leaders Commend OMB Support for Travel to Scientific Conferences, Say Funding is Also Needed
8. Metabolix Executives to Present at Leading Industry Conferences
9. Heptares to Present at Upcoming Biotech Industry Conferences
10. Sigma-Aldrich Corporation Presentations At Three Upcoming Conferences To Be Webcast Live
11. Verenium To Present At Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Raleigh, NC (PRWEB) , ... May 27, 2016 , ... ... after analyzing dozens of studies on the BRCA-1 associated protein (BAP1) gene and its ... on the website. Click here to read the full article now. , ...
(Date:5/26/2016)... Mich. , May 26, 2016  Agriculture nutrients ... Des Moines, Iowa is running their ... Lake Erie and coastal regions ... key to preventing this widespread issue. NECi ... Upper Peninsula, developed a new, easy to ...
(Date:5/26/2016)... Despite the volatility that continues to ... Today,s pre-market research on ActiveWallSt.com directs the investor community,s focus ... RDUS ), Cerus Corp. (NASDAQ: CERS ), ... Prime Therapeutics Inc. (NASDAQ: FPRX ). Register with ... http://www.activewallst.com/ On Wednesday, shares in ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... cuvettes are used in leading laboratories all over the globe. Their cute firefly ... addition to manufacturing awesome cuvettes, FireflySci makes spectrophotometer calibration standards that never require ...
Breaking Biology Technology:
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
(Date:3/21/2016)... , March 22, 2016 ... recognition with passcodes for superior security   ... a leading provider of secure digital communications services, today ... biometric technology and offer enterprise customers, particularly those in ... facial recognition and voice authentication within a mobile app, ...
(Date:3/15/2016)... JERUSALEM , March 15, 2016 ... Jerusalem , the technology-transfer company of the Hebrew University, ... developer of remote sensing technology of various human biological ... funding, raising $2.0 million from private investors. ... technology, based on the detection of electromagnetic emissions from ...
Breaking Biology News(10 mins):